Canada markets open in 26 minutes

PFE Sep 2022 47.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.0300+0.0100 (+50.00%)
As of 03:42PM EDT. Market open.
Full screen
Previous Close0.0200
Open0.0200
Bid0.0000
Ask0.0300
Strike47.00
Expire Date2022-09-23
Day's Range0.0100 - 0.0300
Contract RangeN/A
Volume216
Open Interest1.36k
  • Reuters

    UPDATE 1-Pfizer/BioNTech seek FDA nod for new COVID boosters for children

    Pfizer Inc and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years. The application comes just days after Moderna also applied for FDA authorization of its own Omicron-targeting shot in adolescents aged 12 to 17 years and children aged six to 11. The applications represent a step towards getting children vaccinated by a so-called bivalent vaccine, which targets both the original strain of the virus and the circulating BA.4 and BA.5 subvariants of Omicron.

  • Business Wire

    Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age

    NEW YORK & MAINZ, Germany, September 26, 2022--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) of a 10-µg booster dose of the companies’ Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for children ages 5 through 11 years of age. The request for Emergency Use Authorization of the Omicron BA.4/BA.5-adapted bivalent vaccine in this age group is sup

  • Simply Wall St.

    Little Excitement Around Pfizer Inc.'s (NYSE:PFE) Earnings

    With a price-to-earnings (or "P/E") ratio of 8.4x Pfizer Inc. ( NYSE:PFE ) may be sending bullish signals at the...